Zdrowie i gospodarka · 29/03/2000

FDA Classifies Biotinidase Test System as Class II Device with Special Controls

The FDA has classified the biotinidase test system as a Class II device with special controls, restricting its sale and use to a prescription basis, in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act.